Spectranetics Management Scuffle Outcome To Be Decided By Shareholders
This article was originally published in The Gray Sheet
Former Spectranetics CEO Joseph Largey and Chief Financial Officer Paul Samek could be reinstated to their previous positions if an alternative set of directors is elected at an upcoming shareholder meeting
You may also be interested in...
Incoming Spectranetics President/CEO John Schulte is pledging to fulfill the company's strategic goal to expand indications for the CVX-300 excimer laser, starting with critical limb (lower leg) ischemia
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.